"","x","X.1"
"1","ALKYLATION PROTEIN","GO:0008213"
"2","REDUCED REPRODUCTIVE SUCCESS","GO:0000003"
"3","NA REPRODUCTIVE FAILURE","GO:0000003"
"4","INHIBITION ACTION POTENTIAL","GO:0001508"
"5","ALTERED ACTION POTENTIAL","GO:0001508"
"6","REDUCED PROSTAGLANDIN F2ALPHA SYNTHESIS OVARY","GO:0001516"
"7","DECREASED PROSTAGLANDIN F2ALPHA SYNTHESIS OVARY","GO:0001516"
"8","REDUCTION ANGIOGENESIS","GO:0001525"
"9","INCREASED ANGIOGENESIS","GO:0001525"
"10","ACTIVATION DENDRITIC CELLS","GO:0001775"
"11","STIMULATION OF ADULT LEYDIG CELLS VIA THE ADRENAL CORTICOSTERONE INCREASED GLUCOCORTICOID","GO:0001775"
"12","SUPPRESSION SUPPRESSION OF CYTOKINE PRODUCTION IN THE PRESENCE OF T-CELL ACTIVATION","GO:0001775"
"13","ACTIVATION FIBROBLASTS","GO:0001775"
"14","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION","GO:0001816"
"15","PRODUCTION OF NERVE GROWTH FACTOR EPITHELIAL IRRITATION","GO:0001816"
"16","NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION","GO:0001816"
"17","DEPLETION ENERGY RESERVES DEPLETION ENERGY RESERVES","GO:0001820"
"18","INCREASED SEROTONIN 5-HT INCREASED SEROTONIN 5-HT","GO:0001820"
"19","INCREASED SEROTONIN 5-HT","GO:0001820"
"20","INCREASE CYTOTOXICITY","GO:0001909"
"21","INCREASED PROLIFERATION ENDOTHELIAL CELLS","GO:0001935"
"22","INCREASE DOPAMINERGIC ACTIVITY","GO:0001963"
"23","DECREASED DOPAMINERGIC ACTIVITY","GO:0001963"
"24","SUPPRESSION INFLAMMATORY CYTOKINES","GO:0002534"
"25","ACTIVATION KERATINOCYTES","GO:0002534"
"26","REDUCTION RELEASE OF CIRCULATING CRUSTACEAN CARDIOACTIVE PEPTIDE","GO:0002790"
"27","IMPAIRMENT ENDOTHELIAL NETWORK","GO:0003158"
"28","REDUCED MATURATION INDUCING STEROID RECEPTOR SIGNALLING OOCYTE","GO:0003707"
"29","STABILIZATION PPAR ALPHA CO-REPRESSOR","GO:0003714"
"30","DECREASED DHB4/HSD17B4","GO:0003824"
"31","DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES","GO:0003824"
"32","INHIBITION 5ALPHA-REDUCTASE ACTIVITY","GO:0003824"
"33","INHIBITION PROLYL HYDROXYLASES","GO:0003824"
"34","INHIBITION UROD","GO:0003824"
"35","DECREASE AKT/ENOS ACTIVITY","GO:0003824"
"36","INHIBITION DEIODINASE 2","GO:0003824"
"37","INHIBITION DEIODINASE 1","GO:0003824"
"38","IRREVERSIBLE INHIBITION OF HEPATIC VKOR BY BINDING OF AR AT TYROSINE 139 FAILURE TO CYCLE VITAMIN K EPOXIDE TO VITAMIN K TO FORM VITAMIN K HYDROQUINONE","GO:0003824"
"39","INHIBITION IODOTYROSINE DEIODINASE IYD","GO:0003824"
"40","INHIBITION DEIODINASE 3","GO:0003824"
"41","INHIBITION DUAL OXIDASE","GO:0003824"
"42","INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY","GO:0003824"
"43","DECREASED 3-HYDROXYACYL-COA DEHYDROGENASE TYPE-2 ACTIVITY","GO:0003857"
"44","ACTIVATION 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE GENE","GO:0003857"
"45","INHIBITION ACETYLCHOLINESTERASE ACHE","GO:0003990"
"46","DOWN REGULATION GSS AND GSTS GENE","GO:0004364"
"47","INHIBITION PHOSPHOLIPASE A","GO:0004620"
"48","INHIBITION CYCLOOXYGENASE ACTIVITY","GO:0004666"
"49","INHIBITION CYCLOOXYGENASE 1 ACTIVITY","GO:0004666"
"50","INCREASED INDUCTION OF PYRUVATE DEHYDROGENASE PDH","GO:0004738"
"51","INHIBITION PYRUVATE DEHYDROGENASE KINASE PDK ENZYME","GO:0004738"
"52","ACTIVATION PXR/SXR","GO:0004872"
"53","N/A ANDROGEN RECEPTOR ANTAGONISM","GO:0004882"
"54","AGONISM ANDROGEN RECEPTOR","GO:0004882"
"55","DECREASED ANDROGEN RECEPTOR ACTIVITY","GO:0004882"
"56","ACTIVATION ANDROGEN RECEPTOR","GO:0004882"
"57","BINDING OF AGONIST IONOTROPIC GLUTAMATE RECEPTORS","GO:0004970"
"58","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS","GO:0005102"
"59","ACTIVATION INFLAMMATORY CYTOKINES CHEMOKINES CYTOPROTECTIVE GENE PATHWAYS","GO:0005125"
"60","SP SUBSTANCE P RELEASE LOCAL INCREASE OF SP","GO:0005184"
"61","NEURONAL RELEASE OF CGRP INCREASED CGRP","GO:0005184"
"62","NA INCREASED NEUROKININ A NKA BY NEURONAL CELLS","GO:0005184"
"63","IMPAIRED ION CHANNELS","GO:0005216"
"64","ACTIVATION GLUTAMATE-GATED CHLORIDE CHANNEL","GO:0005254"
"65","ACTIVATION GLUTAMATE-GATED CHLORIDE CHANNELS","GO:0005254"
"66","ALTERED CA2+-CALMODULIN ACTIVATED SIGNAL TRANSDUCTION ALTERED CA2+-CALMODULIN ACTIVATED SIGNAL TRANSDUCTION","GO:0005488"
"67","INCREASED BINDING OF CHEMICALS TO 2U SERUM","GO:0005488"
"68","BINDING TRANSTHYRETIN IN SERUM","GO:0005488"
"69","BINDING FORMATION BINDING OF CALCINEURIN WITH FK506-FKBP COMPLEXES","GO:0005488"
"70","IMMUNOPHILINS BINDING","GO:0005488"
"71","BINDING SH-/SELEN-PROTEINS","GO:0005515"
"72","COVALENT BINDING PROTEIN","GO:0005515"
"73","BINDING OF INHIBITOR NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX I","GO:0006120"
"74","N/A INSUFFICIENT OR INCORRECT DNA REPAIR","GO:0006281"
"75","INCREASED INSUFFICIENT REPAIR OR MIS-REPAIR OF PRO-MUTAGENIC DNA ADDUCTS","GO:0006281"
"76","OVERWHELMED MITOCHONDRIAL DNA REPAIR MECHANISMS","GO:0006281"
"77","INCREASED DNA DAMAGE-REPAIR","GO:0006281"
"78","ALKYLATION DNA","GO:0006305"
"79","FORMATION PRO-MUTAGENIC DNA ADDUCTS","GO:0006305"
"80","ALTERED PROTEIN PRODUCTION","GO:0006412"
"81","DECREASED THYROID HORMONE SYNTHESIS","GO:0006590"
"82","ALTERATION LIPID METABOLISM","GO:0006629"
"83","SYNTHESIS DE NOVO FA","GO:0006633"
"84","INCREASED DE NOVO FA SYNTHESIS","GO:0006633"
"85","DECREASED DE NOVO FA SYNTHESIS","GO:0006633"
"86","DECREASED PEROXISOMAL FATTY ACID BETA OXIDATION OF FATTY ACIDS","GO:0006635"
"87","DECREASED MITOCHONDRIAL FATTY ACID BETA OXIDATION","GO:0006635"
"88","DECREASED MITOCHONDRIAL FATTY ACID BETA-OXIDATION","GO:0006635"
"89","INHIBITION MITOCHONDRIAL FATTY ACID BETA-OXIDATION","GO:0006635"
"90","UP REGULATION UNSATURATED FATTY ACID","GO:0006636"
"91","DECREASED STEROIDOGENESIS PROTEOMIC ALTERATIONS IN THE ADULT LEYDIG CELL","GO:0006694"
"92","DECREASED CHOLESTEROL DECREASED DE NOVO BIOSYNTHESIS OF CHOLESETEROL","GO:0006695"
"93","REDUCTION 17BETA-ESTRADIOL SYNTHESIS BY OVARIAN GRANULOSA CELLS","GO:0006703"
"94","REDUCTION IN OVARIAN GRANULOSA CELLS SYNTHESIS OF ESTRADIOL REDUCED STEROIDOGENIC PRODUCTION OF ESTRADIOL IN GRANULOSA CELLS","GO:0006703"
"95","DECREASED ATP PRODUCTION","GO:0006754"
"96","UNCOUPLING OF OXIDATIVE PHOSPHORYLATION REDUCED ABILITY TO GENERATE ATP","GO:0006754"
"97","DEPLETION NITRIC OXIDE","GO:0006809"
"98","DECREASED CALCIUM INFLUX","GO:0006816"
"99","REDUCTION CA AND HCO3 TRANSPORT TO SHELL GLAND","GO:0006816"
"100","OPENING OF CALCIUM CHANNEL CALCIUM INFLUX","GO:0006816"
"101","REDUCTION CHOLESTEROL TRANSPORT IN MITOCHONDRIA","GO:0006839"
"102","REDUCTION VITELLOGENIN ACCUMULATION INTO OOCYTES AND OOCYTE GROWTH/DEVELOPMENT","GO:0006898"
"103","INCREASED LDL UPTAKE","GO:0006898"
"104","CHANGES/INHIBITION CELLULAR HOMEOSTASIS AND APOPTOSIS","GO:0006915"
"105","INCREASED APOPTOSIS DECREASED NUMBER OF ADULT LEYDIG CELLS","GO:0006915"
"106","DECREASED STEROIDOGENESIS INCREASED APOPTOSIS OF ADULT LEYDIG CELLS","GO:0006915"
"107","APOPTOSIS OF ADULT LEYDIG CELLS DECREASED TESTOSTERONE BY ADULT LEYDIG CELLS","GO:0006915"
"108","DECREASED APOPTOSIS EPITHELIAL CELLS","GO:0006915"
"109","NA APOPTOSIS","GO:0006915"
"110","REDUCTION ABDOMINAL MUSCLE CONTRACTION","GO:0006936"
"111","OVERACTIVATION MUSCLE CONTRACTION","GO:0006936"
"112","INCREASE INFLAMMATION","GO:0006954"
"113","NA SYSTEMIC INFLAMMATION LEADING TO HEPATIC STEATOSIS","GO:0006954"
"114","INCREASE INFLAMMATION CORNEAL CELLS","GO:0006954"
"115","INFILTRATION INFLAMMATORY CELLS","GO:0006954"
"116","INCREASED INFLAMMATION","GO:0006954"
"117","LEUKOCYTE RECRUITMENT IMMUNE SYSTEM RESPONSE","GO:0006954"
"118","CHRONIC COUGH RESPIRATORY IRRITABILITY","GO:0006954"
"119","SENSITIZATION IMMUNE SYSTEM","GO:0006955"
"120","NA NARCOSIS","GO:0007009"
"121","DECREASED STEROIDOGENESIS ALTERATIONS IN THE LEYDIG CELL CYTOSKELETON","GO:0007010"
"122","DISORGANIZATION SPINDLE","GO:0007051"
"123","INCREASED CHROMOSOME MISSEGGREGATION","GO:0007059"
"124","INHIBITION NUCLEAR FACTOR KAPPA B NF-KB","GO:0007249"
"125","DECREASED HIPPOCAMPAL FUNCTION","GO:0007268"
"126","REDUCTION NEURONAL SYNAPTIC INHIBITION","GO:0007268"
"127","OVERACTIVATION NEURONOTRANSMITTER RELEASE","GO:0007269"
"128","DECREASED KISSPEPTIN RELEASE FROM NEURONS IN AVPV DECREASED HYPOTHALAMIC ESTROGEN REDUCES KISSPEPTINERGIC NEURON RESPONSE","GO:0007269"
"129","DECREASED SYNAPTOGENESIS","GO:0007416"
"130","ACCELERATED AGING","GO:0007568"
"131","INCREASE BILIARY EXCRETION TH GLUCURONIDE","GO:0007588"
"132","IMPAIRMENT LEARNING AND MEMORY","GO:0007612"
"133","INSUFFICIENCY VASCULAR","GO:0008015"
"134","INHIBITION NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX I","GO:0008137"
"135","PRODUCTION CRITICAL METABOLITES CGA 330050 AND CGA 265307","GO:0008152"
"136","METABOLISM OF AFB1 PRODUCTION OF REACTIVE ELECTROPHILES","GO:0008152"
"137","INCREASED CLEARANCE OF THYROXINE FROM TISSUES","GO:0008152"
"138","PROLIFERATION CELL PROLIFERATION IN THE ABSENCE OF CYTOTOXICITY","GO:0008283"
"139","ACTIVATION/PROLIFERATION T-CELLS","GO:0008283"
"140","ALTERATIONS CELLULAR PROLIFERATION / HYPERPLASIA","GO:0008283"
"141","INCREASE PROLIFERATION LEYDIG CELL","GO:0008283"
"142","INCREASE MITOGENIC CELL PROLIFERATION HEPATOCYTES","GO:0008283"
"143","INCREASE HYPERTROPHY AND PROLIFERATION FOLLICULAR CELL","GO:0008283"
"144","INCREASE REGENERATIVE CELL PROLIFERATION CORNEAL CELLS","GO:0008283"
"145","INCREASE REGENERATIVE CELL PROLIFERATION FORESTOMACH EPITHELIAL CELLS","GO:0008283"
"146","INCREASE REGENERATIVE CELL PROLIFERATION HEPATOCYTES","GO:0008283"
"147","INCREASE REGENERATIVE CELL PROLIFERATION UROTHELIAL CELLS","GO:0008283"
"148","INCREASE CELL PROLIFERATION","GO:0008283"
"149","INCREASE PROLIFERATION OF GOBLET CELLS","GO:0008283"
"150","INCREASED HYPERTROPHY AND PROLIFERATION FOLLICULAR CELL","GO:0008283"
"151","PROLIFERATION/CLONAL EXPANSION SMOOTH MUSCLE","GO:0008283"
"152","INCREASED CELLULAR PROLIFERATION / HYPERPLASIA OF ACINAR CELLS","GO:0008283"
"153","PROLIFERATION/CLONAL EXPANSION ABERRANT BASAL CELLS","GO:0008283"
"154","INCREASED CELL PROLIFERATION MESOTHELIUM","GO:0008283"
"155","INCREASE CELL PROLIFERATION EPITHELIAL CELLS","GO:0008283"
"156","INCREASED TRIGLYCERIDE FORMATION","GO:0009058"
"157","INCREASED TRIGLYCERIDE","GO:0009058"
"158","DECREASE TETRAHYDROBIOPTERIN","GO:0009058"
"159","NA ROS FORMATION","GO:0009058"
"160","ACCUMULATION DAMAGED MITOCHONDRIAL DNA","GO:0009611"
"161","INCREASED DEVELOPMENTAL DEFECTS","GO:0009653"
"162","NA DEFECT OF EMBRYOGENESIS","GO:0009790"
"163","INCREASED PROLIFERATION OF MESENCHYMAL CELLS","GO:0010463"
"164","ALTERED HIPPOCAMPAL GENE EXPRESSION","GO:0010468"
"165","DECREASED TRANSCRIPTION OF GENES BY AR","GO:0010468"
"166","ALTERED GENE EXPRESSION SPECIFIC TO CAR ACTIVATION HEPATOCYTES ALTERED GENE EXPRESSION SPECIFIC TO CAR ACTIVATION HEPATOCYTES","GO:0010468"
"167","ACTIVATION NICOTINIC ACETYLCHOLINE RECEPTOR","GO:0015464"
"168","BINDING TUBULIN","GO:0015631"
"169","INCREASED FA INFLUX","GO:0015908"
"170","ALTERATION WNT PATHWAY","GO:0016055"
"171","OXIDATION GLUTATHIONE","GO:0016209"
"172","ACTIVATION SP1","GO:0016310"
"173","ALTERED REPRODUCTIVE BEHAVIOUR","GO:0019098"
"174","REDUCED BROOD CARE","GO:0019098"
"175","REDUCTION ECDYSIS MOTONEURON BURSTS","GO:0019226"
"176","GENERATION OF NOVEL EPITOPES ANTIGEN PRESENTATION","GO:0019882"
"177","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS","GO:0019904"
"178","INCREASED SECOND MESSENGER PRODUCTION","GO:0019932"
"179","INCREASED REPRODUCTIVE SUCCESS","GO:0022414"
"180","REDUCTION IONOTROPIC GABA RECEPTOR CHLORIDE CHANNEL CONDUCTANCE","GO:0022851"
"181","ACTIVATION IONOTROPIC GABA RECEPTOR CHLORIDE CHANNEL","GO:0022851"
"182","NA DIFFERENTIATION OF MYOFIBROBLAST","GO:0030154"
"183","INCREASED CATABOLISM OF MUSCLE PROTEIN","GO:0030163"
"184","AGONISM ESTROGEN RECEPTOR","GO:0030284"
"185","ANTAGONISM ESTROGEN RECEPTOR","GO:0030284"
"186","DECREASED TESTOSTERONE BY THE FETAL LEYDIG CELLS ACTIVATION BY OTHER ESTRADIOL AGONISTS","GO:0030284"
"187","INCREASED ESTROGEN RECEPTOR ER ACTIVITY","GO:0030284"
"188","SUPPRESSION ESTROGEN RECEPTOR ER ACTIVITY","GO:0030284"
"189","PREPUBERTAL INCREASE ESTROGEN RECEPTOR ER ACTIVITY","GO:0030284"
"190","INCREASED ER BINDING TO DNA CLASSICAL PATHWAY","GO:0030331"
"191","INCREASED ER BINDING TO TF TO DNA NON-CLASSICAL PATHWAY","GO:0030331"
"192","ACTIVATION ESTROGEN RECEPTOR ALPHA","GO:0030520"
"193","DESENSITIZATION NICOTINIC ACETYLCHOLINE RECEPTOR","GO:0030545"
"194","DESENSITIZATION NICOTINIC ACETYLCHOLINE RECEPTOR DESENSITIZATION NICOTINIC ACETYLCHOLINE RECEPTOR","GO:0030549"
"195","DECREASE OVULATION","GO:0030728"
"196","SUPPRESSION IL-2 AND IL-4 PRODUCTION","GO:0032623"
"197","ACCUMULATION COLLAGEN","GO:0032964"
"198","NA EXPRESSION OF COLLAGEN","GO:0032964"
"199","ACTIVATION PPARALPHA","GO:0035357"
"200","ACTIVATION PPARGAMMA","GO:0035357"
"201","DECREASED PPAR-ALPHA ACTIVATION","GO:0035357"
"202","DECREASED PPAR-BETA ACTIVATION","GO:0035357"
"203","DECREASED PPAR-GAMMA ACTIVATION","GO:0035357"
"204","INHIBITION PPAR ALPHA","GO:0035357"
"205","ACTIVATION OF SPECIFIC NUCLEAR RECEPTORS PPAR-GAMMA ACTIVATION","GO:0035357"
"206","INCREASED PPAR-ALPHA ACTIVATION","GO:0035357"
"207","NA INACTIVATION OF PPAR??","GO:0035357"
"208","DECREASED PPARALPHA TRANSACTIVATION OF GENE EXPRESSION","GO:0035624"
"209","DECREASED TESTOSTERONE BY THE FETAL LEYDIG CELLS INCREASED COUP-TFII IN FETAL LEYDIG CELLS","GO:0035624"
"210","DECREASED NUMBER AND FUNCTION OF ADULT LEYDIG CELLS DECREASED COUP-TFII STEM LEYDIG CELLS","GO:0035624"
"211","DECREASED TESTOSTERONE BY THE FETAL LEYDIG CELLS DECREASED COUP-TFII STEM LEYDIG CELLS","GO:0035624"
"212","N/A NEURONAL DYSFUNCTION","GO:0036475"
"213","INCREASED LOCOMOTION","GO:0040011"
"214","INCREASED MUSCULAR WAVES IN FOOT","GO:0040011"
"215","DECREASED LOCOMOTION","GO:0040011"
"216","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE","GO:0042060"
"217","INCREASED ACTIVATION AND RECRUITMENT OF HEPATIC MACROPHAGES KUPFFER CELLS","GO:0042116"
"218","ACTIVATION MACROPHAGES","GO:0042116"
"219","IMPAIRED VASODILATION","GO:0042311"
"220","DECREASED SYNTHESIS OF NE","GO:0042421"
"221","INCREASE LUTEINIZING HORMONE LH","GO:0042446"
"222","N/A REPRESSED EXPRESSION OF STEROIDOGENIC ENZYMES","GO:0042446"
"223","INCREASED T4/T3 CATABOLISM","GO:0042447"
"224","FORMATION FORMATION OF HEMOGLOBIN ADDUCTS","GO:0042541"
"225","IRREGULARITIES OVARIAN CYCLE","GO:0042698"
"226","OVULATION OF OOCYTES REDUCED DELAYED OR BLOCKED DECREASE OR DELAY IN LH SURGE REQUIRED FOR OVULATION","GO:0042698"
"227","DECREASED PROGESTERONE FROM CORPUS LUTEUM","GO:0042701"
"228","INCREASED MIGRATION ENDOTHELIAL CELLS","GO:0043542"
"229","ANTICOAGULANT RODENTICIDE INTERFERES WITH CARBOXYLATION OF GLA PROTEINS IN BONE IMPAIRMENT OF POST-TRANSLATIONAL MODIFICATION CARBOXYLATION OF OSTEOCALCIN","GO:0043687"
"230","SUPPRESSION IMMUNE SYSTEM","GO:0044414"
"231","RELAXATION SMOOTH MUSCLE","GO:0044557"
"232","N/A REPRODUCTIVE FAILURE","GO:0044703"
"233","INCREASE OXIDATIVE METABOLISM","GO:0045333"
"234","INCREASED ADIPOGENESIS","GO:0045444"
"235","DECREASED GLUCOSE OXIDASE ENZYME ACTIVITY","GO:0046562"
"236","DECREASED GNRH PULSATILITY/RELEASE","GO:0046879"
"237","DECREASED LH SURGE","GO:0046879"
"238","DECREASED GNRH RELEASE DECREASED KISSPEPTIN STIMULATION OF GNRH NEURONS","GO:0046879"
"239","INCREASED SECRETION OF GNRH FROM HYPOTHALAMUS","GO:0046879"
"240","DECREASED GNRH PULSATILITY/RELEASE IN HYPOTHALAMUS","GO:0046879"
"241","DECREASED LH SURGE FROM ANTERIOR PITUITARY","GO:0046879"
"242","INCREASED SECRECTION OF FSH FROM ANTERIOR PITUITARY","GO:0046884"
"243","REDUCED RELEASE OF BDNF","GO:0046903"
"244","SUPPRESSION VLDL SECRETION","GO:0046903"
"245","DECREASED CORTICAL GRANULE RELEASE/DISTRIBUTION UPON FERTILIZATION","GO:0046903"
"246","INCREASE MUCIN PRODUCTION","GO:0046903"
"247","INCREASED SECRETION OF LOCAL GROWTH FACTORS","GO:0046903"
"248","DIMERIZATION AHR/ARNT DIMERIZATION AHR/ARNT","GO:0046983"
"249","DIMERIZATION AHR/ARNT","GO:0046983"
"250","REDUCED DIMERIZATION ARNT/HIF1-ALPHA","GO:0046983"
"251","BINDING OF ANTAGONIST PPAR ALPHA","GO:0048019"
"252","INCREASED GAMETE MATURATION","GO:0048469"
"253","ABERRANT DENDRITIC MORPHOLOGY","GO:0048813"
"254","ALTERED NEUROANATOMY","GO:0048856"
"255","INCREASED MOTILITY","GO:0048870"
"256","RELEASE CYTOKINE","GO:0050663"
"257","DECREASED HYDROGEN PEROXIDE PRODUCTION","GO:0050665"
"258","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS","GO:0050673"
"259","INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS","GO:0050673"
"260","INCREASED NEURONAL SYNAPTIC INHIBITION","GO:0050805"
"261","DECREASED STEROIDOGENESIS DECREASED ACTIVITY OF STEROIDOGENIC ENZYMES IN ADULT LEYDIG CELLS","GO:0050810"
"262","DIRECT EFFECTS OF CORTICOSTERONE ON STEROIDOGENESIS DECREASED TESTOSTERONE BY ADULT LEYDIG CELLS","GO:0050810"
"263","DECREASED COGNITIVE FUNCTION","GO:0050890"
"264","DECREASED BINDING OF NE TO NE RECEPTORS ON GNRH NEURONS","GO:0051380"
"265","INHIBITION REUPTAKE OF 5-HT 5-HYDROXYTRYPTAMINE TRANSPORTER; SODIUM-DEPENDENT SEROTONIN TRANSPORTER","GO:0051610"
"266","OCCURRENCE A PAROXYSMAL DEPOLARIZING SHIFT","GO:0051899"
"267","PROLONGED DEPOLARIZATION OF NEURONAL MEMBRANE","GO:0051899"
"268","LIPID MEMBRANES PROTEINS DNA OXIDATION OF BIOMOLECULES","GO:0055114"
"269","INCREASED INHIBITORY POSTSYNAPTIC POTENTIAL","GO:0060080"
"270","INCREASE TRANSDIFFERENTIATION OF CILIATED EPITHELIAL CELLS","GO:0060290"
"271","DECREASED LONG-TERM POTENTIATION LTP","GO:0060291"
"272","REDUCTION TESTOSTERONE SYNTHESIS IN LEYDIG CELLS","GO:0061370"
"273","REDUCTION TESTOSTERONE SYNTHESIS BY OVARIAN THECA CELLS","GO:0061370"
"274","DECREASED CHOLESTEROL DECREASED TESTOSTERONE PRODUCTION BY ADULT LEYDIG CELLS","GO:0061370"
"275","DECREASE BIOACTIVATION OF TESTOSTERONE","GO:0061370"
"276","INCREASE TISSUE DEGENERATION NECROSIS & ATROPHY","GO:0070265"
"277","NA NECROSIS","GO:0070265"
"278","REDUCTION IN OVARIAN GRANULOSA CELLS AROMATASE CYP19A1","GO:0070330"
"279","INHIBITION AROMATASE","GO:0070330"
"280","DECREASED AROMATASE CYP19A1 MRNA","GO:0070330"
"281","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION","GO:0072358"
"282","DECREASED NEURONAL NETWORK FUNCTION","GO:0099536"
"283","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN","GO:0099536"
"284","INCREASED CHLORIDE CONDUCTANCE","GO:1902476"
"285","DISRUPTION LYSOSOME","GO:1903008"
"286","DECREASE GTPCH-1","GO:1903009"
"287","INCREASED ROS PRODUCTION","GO:1903409"
"288","PRODUCTION REACTIVE OXYGEN SPECIES","GO:1903409"
"289","DECREASE APOPTOSIS OF CILIATED EPITHELIAL CELLS","GO:1904019"
"290","BLOOD LOSS AND DEVELOPMENT OF ANEMIA IMPAIRED OXYGEN DELIVERY AND NUTRIENT DELIVERY TO TISSUE IMPAIRED CARBON DIOXIDE AND WASTE PRODUCT REMOVAL","GO:1990748"
"291","INCREASE FA INFLUX","GO:2000193"
"292","DECREASED KETOGENESIS PRODUCTION OF KETONE BODIES","CTOME SYNTHESIS OF KETONE BODIES"
"293","ACTIVATION GLUCOCORTICOID RECEPTOR","GLUCOCORTICOID RECEPTOR PATHWAY"
"294","ACTIVATION GLUCOCORTICOID RECEPTOR AGONIST","GLUCOCORTICOID RECEPTOR PATHWAY"
"295","INCREASED ACTIVITY BETA-2 ADRENERGIC RECEPTOR","ADRENERGIC RECEPTOR SIGNALING PATHWAY"
"296","ACTIVATION EGFR","CTOME SIGNALING BY EGFR"
"297","DEPOLYMERIZATION MICROTUBULE","MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION"
"298","UP REGULATION LDLR LOW DENSITY LIPOPROTEIN RECEPTOR","LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS"
"299","ALTERED GENE EXPRESSION","POSITIVE REGULATION OF GENE EXPRESSION"
"300","SUPPRESSION CONSTITUTIVE ANDROSTANE RECEPTOR NR1L3","CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY"
"301","ACTIVATION NRF2","NRF2 PATHWAY"
"302","ACTIVATION CONSTITUTIVE ANDROSTANE RECEPTOR","CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY"
"303","ACTIVATION HEPATIC NUCLEAR RECEPTORS","NUCLEAR RECEPTORS"
"304","ACTIVATION ESTROGEN RECEPTOR","ESTROGEN RECEPTOR PATHWAY"
"305","ACTIVATION BETA-2 ADRENERGIC RECEPTOR","ADRENERGIC RECEPTOR SIGNALING PATHWAY"
"306","INHIBITION VEGFR2","CTOME VEGFR2 MEDIATED CELL PROLIFERATION"
"307","UPREGULATED SPINDLE ASSEMBLY CHECKPOINT PROTEIN MAD2-OOCYTE","REGULATION OF SPINDLE CHECKPOINT"
"308","PROPAGATION OXIDATIVE STRESS","OXIDATIVE STRESS"
"309","INCREASED DNA DAMAGE","DNA DAMAGE RESPONSE"
"310","HYPERPLASIA LEYDIG CELL","LEYDIG CELL DIFFERENTIATION"
"311","INHIBITION INDUCIBLE NITRIC OXIDE SYNTHASE BY METABOLITE CGA 265307","REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY"
"312","NA GLUTATHIONE SYNTHESIS","GLUTATHIONE METABOLIC PROCESS"
"313","ALTERED REGULATION ALPHA HEMOGLOBIN","HEMOGLOBIN METABOLIC PROCESS"
"314","ACTIVATION JNK","JNK CASCADE"
"315","ACTIVATION FOXO","CTOME FOXO MEDIATED TRANSCRIPTION"
"316","INHIBITION WNT PATHWAY","REGULATION OF WNT SIGNALING PATHWAY"
"317","DECREASE INTRACELLULAR PH","REGULATION OF PH"
"318","INCREASE LEYDIG CELL TUMORS","LEYDIG CELL DIFFERENTIATION"
"319","N/A OXIDATIVE STRESS","OXIDATIVE STRESS"
"320","INCREASE OXIDATIVE STRESS","OXIDATIVE STRESS"
"321","INCREASED OXIDATIVE STRESS INCREASED OXIDATIVE STRESS","OXIDATIVE STRESS"
"322","INCREASED OXIDATIVE STRESS","OXIDATIVE STRESS"
"323","DISRUPTION MITOCHONDRIAL ELECTRON TRANSPORT CHAIN","ELECTRON TRANSPORT CHAIN"
"324","DECREASED NITRIC OXIDE","RESPONSE TO NITRIC OXIDE"
"325","ACCUMULATION TRIGLYCERIDE","TRIGLYCERIDE METABOLIC PROCESS"
"326","DECREASED MEVALONATE","MEVALONATE PATHWAY"
"327","DISTURBANCE LYSOSOMAL FUNCTION","LYSOSOMAL TRANSPORT"
"328","INJURY MITOCHONDRIA","RESPONSE TO AXON INJURY"
"329","INCREASED REACTIVE OXYGEN SPECIES","RESPONSE TO REACTIVE OXYGEN SPECIES"
"330","MODULATION EXTRACELLULAR MATRIX COMPOSITION","EXTRACELLULAR MATRIX ASSEMBLY"
"331","NA GLUTATHIONE HOMEOSTASIS","GLUTATHIONE METABOLIC PROCESS"
"332","INCREASE HYPERPLASIA RENAL TUBULAR CELLS","RENAL TUBULAR DYSFUNCTION"
"333","INCREASE HYPERPLASIA TERMINAL BRONCHIOLAR CELLS","ADRENAL HYPERPLASIA"
"334","INCREASE HYPERPLASIA FOLLICULAR CELLS","ADRENAL HYPERPLASIA"
"335","INCREASE HYPERPLASIA UROTHELIAL","ADRENAL HYPERPLASIA"
"336","HYPERPLASIA OVARIAN STROMAL CELLS","ADRENAL HYPERPLASIA"
"337","INCREASED HYPERPLASIA GLANDULAR EPITHELIAL CELLS OF ENDOMETRIUM","ABNORMALITY OF THE ENDOMETRIUM"
"338","INCREASED LACTOTROPH HYPERPLASIA AND HYPERTROPHY","ADRENAL HYPERPLASIA"
"339","HYPERTROPHY/HYPERPLASIA SMOOTH MUSCLE","SMOOTH PHILTRUM"
"340","DECREASED KETOGENESIS","DECREASED FERTILITY"
"341","INCREASED INDUCED MUTATIONS IN CRITICAL GENES","GENES INVOLVED IN MALE INFERTILITY"
"342","NA IN UTERO MLL CHROMOSOMAL TRANSLOCATION","CHROMOSOMAL AND MICROSATELLITE INSTABILITY IN COLORECTAL CANCER"
"343","IMPAIRED PROTEOSTASIS","IMPAIRED PROPRIOCEPTION"
"344","DECREASED TESTOSTERONE BY THE FETAL LEYDIG CELLS ACTIVATION BY OTHER GLUCOCORTICOID RECEPTOR AGONISTS","ABNORMALITY OF THE LEYDIG CELLS"
"345","GLUCOCORTICOID RECEPTOR MEDIATED ALTERATIONS IN STERIODOGENIC ENZYMES DECREASED TESTOSTERONE BY ADULT LEYDIG CELLS","ABNORMALITY OF THE LEYDIG CELLS"
"346","INCREASED UPTAKE OF THYROXINE INTO TISSUE","NEOPLASM OF FATTY TISSUE"
"347","DECREASED SODIUM CONDUCTANCE","ABNORMAL BLOOD SODIUM CONCENTRATION"
"348","DECREASED GABA RELEASE","DECREASED LEVEL OF GABA IN SERUM"
"349","INDUCTION IKB INHIBITORY PROTEIN","ABNORMAL CIRCULATING PROTEIN CONCENTRATION"
"350","N/A CELL INJURY/DEATH","CELL CYCLE"
"351","INCREASE CYTOTOXICITY RENAL TUBULAR CELL","RENAL TUBULAR DYSFUNCTION"
"352","INCREASE CYTOTOXICITY CLUB CELLS","ABNORMALITY OF THE LEYDIG CELLS"
"353","INCREASE CYTOTOXICITY CORNEAL CELLS","ABNORMALITY OF CORNEAL SIZE"
"354","INCREASE CYTOTOXICITY EPITHELIAL CELLS","REGUCALCIN IN PROXIMAL TUBULE EPITHELIAL KIDNEY CELLS"
"355","INCREASE CYTOTOXICITY TUBULAR EPITHELIAL CELLS","RENAL TUBULAR DYSFUNCTION"
"356","INCREASE CYTOTOXICITY HEPATOCYTES","LIPID ACCUMULATION IN HEPATOCYTES"
"357","INCREASE CYTOTOXICITY UROTHELIAL CELLS","ABNORMALITY OF THE LEYDIG CELLS"
"358","PERSISTENT CYTOTOXICITY PLEURA OR PERITONEUM","ABNORMAL PLEURA MORPHOLOGY"
"359","INCREASE NECROSIS TERMINAL BRONCHIOLAR CELLS","HEPATIC NECROSIS"
"360","DECREASED SECRETION OF ECDYSIS TRIGGERING HORMONE ETH","DECREASED CIRCULATING LUTEINIZING HORMONE LEVEL"
"361","REDUCED MEIOTIC PROPHASE I/METAPHASE I TRANSITION OOCYTE","REDUCED CIRCULATING PROLACTIN CONCENTRATION"
"362","DECREASE STEROIDOGENIC ACUTE REGULATORY PROTEIN STAR","ANGIOPOIETIN LIKE PROTEIN 8 REGULATORY PATHWAY"
"363","DECREASE TRANSLOCATOR PROTEIN TSPO","SLOW DECREASE IN VISUAL ACUITY"
"364","ACTIVATION OF SPECIFIC NUCLEAR RECEPTORS TRANSCRIPTIONAL CHANGE","NUCLEAR RECEPTORS"
"365","DOWN REGULATION GULCOSE-6-PHOSPHATE DEHYDROGENASE","ABNORMAL LACTATE DEHYDROGENASE LEVEL"
"366","DECREASED HSD17B10 EXPRESSION","DECREASED FACIAL EXPRESSION"
"367","INCREASED VITELLOGENIN SYNTHESIS","EICOSANOID SYNTHESIS"
"368","DECREASED PCK1 EXPRESSION CONTROL POINT FOR GLYCOLYSIS/GLUCONEOGENESIS PATHWAY","DECREASED FACIAL EXPRESSION"
"369","INCREASED HIF-1 HETERODIMER","INCREASED HEMOGLOBIN"
"370","INCREASED HIF-1 ALPHA TRANSCRIPTION","PPAR ALPHA PATHWAY"
"371","REDUCED PRODUCTION VEGF","ANEMIA OF INADEQUATE PRODUCTION"
"372","INCREASED INDUCTION OF UDPGT'S IN LIVER","ABNORMALITY OF THE LIVER"
"373","INCREASED IGF-1 MOUSE","INCREASED HEMOGLOBIN"
"374","PROMOTION SIX-1 POSTIVE BASAL-TYPE PROGENITOR CELLS","CARDIAC PROGENITOR DIFFERENTIATION"
"375","NA PRODUCTION OF ?±-SMOOTH MUSCLE ACTIN","REGULATION OF ACTIN CYTOSKELETON"
"376","UP REGULATION SREBF2","SLEEP REGULATION"
"377","DECREASED THYROIDAL IODIDE UPTAKE","DECREASED FERTILITY"
"378","DECREASED UPTAKE OF INORGANIC IODIDE","ABNORMAL BLOOD INORGANIC CATION CONCENTRATION"
"379","ACTIVATION LONG TERM AHR RECEPTOR DRIVEN DIRECT AND INDIRECT GENE EXPRESSION CHANGES","MITOCHONDRIAL GENE EXPRESSION"
"380","ACTIVATION MTTP","NANOPARTICLEMEDIATED ACTIVATION OF RECEPTOR SIGNALING"
"381","INCREASED NON-GENOMIC SIGNALING","INCREASED HEMOGLOBIN"
"382","INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK","OXIDATIVE STRESS"
"383","ACTIVATION HIF-1","16P112 DISTAL DELETION SYNDROME"
"384","ACTIVATION JAK/STAT PATHWAY","NANOPARTICLEMEDIATED ACTIVATION OF RECEPTOR SIGNALING"
"385","ACTIVATION TGF-BETA PATHWAY","NANOPARTICLEMEDIATED ACTIVATION OF RECEPTOR SIGNALING"
"386","DECREASED LH RELEASE FROM ANTERIOR PITUITARY DECREASED GNRH STIMULATION OF ANTERIOR PITUITARY GONADOTROPHS","ANTERIOR PITUITARY AGENESIS"
"387","INCREASED SECRETION OF LH FROM ANTERIOR PITUITARY","ANTERIOR PITUITARY AGENESIS"
"388","UP REGULATION TGFBETA1 EXPRESSION","ABNORMAL FACIAL EXPRESSION"
"389","ABNORMAL SPERM PENETRATION POLYSPERMY","ABNORMAL METABOLISM"
"390","ACTIVATION STELLATE CELLS","NANOPARTICLEMEDIATED ACTIVATION OF RECEPTOR SIGNALING"
"391","INHIBITION HMG-COA REDUCTASE","LET7 INHIBITION OF ES CELL REPROGRAMMING"
"392","DECREASE HISTAMINERGIC NEURON EXCITATION","ABNORMAL NEURON MORPHOLOGY"
"393","NERVE EXCITATION BRONCHOPULMONARY VAGUL NERVE EXCITATION","ABNORMAL CRANIAL NERVE MORPHOLOGY"
"394","OCCURRENCE CYTOPLASMIC VACUOLIZATION HEPATOCYTE","SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR"
"395","OCCURRENCE BALLOONING DEGENERATION HEPATOCYTE","SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR"
"396","OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL","ABNORMAL LACRIMAL DUCT MORPHOLOGY"
"397","OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL","CYTOPLASMIC RIBOSOMAL PROTEINS"
"398","ALTERED MEIOTIC CHROMOSOME DYNAMICS","CHROMOSOME BREAKAGE"
"399","HYPERPOLARISATION NEURON","ABNORMAL NEURON MORPHOLOGY"
"400","DAMAGING MITOCHONDRIA","ABNORMAL MITOCHONDRIA IN MUSCLE TISSUE"
"401","INDUCTION SUSTAINED CELL PROLIFERATION","DRUG INDUCTION OF BILE ACID PATHWAY"
"402","INCREASE HYPERPLASIA LEYDIG CELLS","ABNORMALITY OF THE LEYDIG CELLS"
"403","INCREASE PRENEOPLASTIC FOCI HEPATOCYTES","LIPID ACCUMULATION IN HEPATOCYTES"
"404","ALTERED GABAERGIC INTERNEURONS MORPHOLOGY AND FUNCTION","DECREASED PULMONARY FUNCTION"
"405","ALTERED CHROMOSOME NUMBER POLYPLOID ZYGOTE","CHROMOSOME BREAKAGE"
"406","ALTERED CHROMOSOME NUMBER","CHROMOSOME BREAKAGE"
"407","INCREASE HYPERPLASIA TUBULAR EPITHELIAL CELLS","ADRENAL HYPERPLASIA"
"408","INCREASE HYPERPLASIA FORESTOMACH EPITHELIAL CELLS","ADRENAL HYPERPLASIA"
"409","INCREASE HYPERPLASIA GLANDULAR EPITHELIAL CELLS OF ENDOMETRIUM","ABNORMALITY OF THE ENDOMETRIUM"
"410","FORMATION MALLORY BODY","SPARSE BODY HAIR"
"411","N/A MITOCHONDRIAL DYSFUNCTION","MUSCLE ABNORMALITY RELATED TO MITOCHONDRIAL DYSFUNCTION"
"412","ACCUMULATION ACETYLCHOLINE IN SYNAPSES","IRON ACCUMULATION IN BRAIN"
"413","DEPLETION GSH","16P112 DISTAL DELETION SYNDROME"
"414","INCREASE CA++ INTRACELLULAR","NOVEL INTRACELLULAR COMPONENTS OF RIGILIKE RECEPTOR RLR PATHWAY"
"415","BILE ACCUMULATION PATHOLOGICAL CONDITION","IRON ACCUMULATION IN BRAIN"
"416","DAMAGING RED BLOOD CELLS; HEMOLYSIS","RED EYE"
"417","N/A UNKNOWN","16P112 DISTAL DELETION SYNDROME"
"418","ACCUMULATION BIOLOGICAL MEMBRANES","IRON ACCUMULATION IN BRAIN"
"419","DISRUPTION MEMBRANE INTEGRITY","THINNING OF DESCEMET MEMBRANE"
"420","INCREASED INTRACELLULAR CALCIUM OVERLOAD","ABNORMALITY OF URINE CALCIUM CONCENTRATION"
"421","DECREASED TESTOSTERONE BY THE FETAL LEYDIG CELLS INCREASED CORTICOSTERONE","ABNORMALITY OF THE LEYDIG CELLS"
"422","DECREASED TESTOSTERONE BY THE FETAL LEYDIG CELLS INCREASED ESTRADIOL","ABNORMALITY OF THE LEYDIG CELLS"
"423","ALTERED FORMATION OF CORTICAL ENVELOPE","CORTICAL DYSPLASIA"
"424","INCREASE PAPILLOMAS/CARCINOMAS SQUAMOUS CELLS","SQUAMOUS CELL CARCINOMA"
"425","DECREASED CHOLESTEROL","ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION"
"426","DAMAGE LIPID BILAYER","LIPID METABOLISM PATHWAY"
"427","OXIDATION UROPORPHYRINOGEN","FATTY ACID BETA OXIDATION"
"428","UNCOUPLING ENOS","16P112 DISTAL DELETION SYNDROME"
"429","PROMOTION OVARIAN GRANULAR CELL TUMORS","ABNORMAL OVARIAN MORPHOLOGY"
"430","DECREASED TRIIODOTHYRONINE T3 IN SERUM","DECREASED LEVEL OF GABA IN SERUM"
"431","INCREASED INVASION","CELL MIGRATION AND INVASION THROUGH P75NTR"
"432","NA PERTURBATION OF CHOLESTEROL","ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION"
"433","INCREASED CARDIAC ARRTHYMIA","ABNORMAL CARDIAC TEST"
"434","OCCURRENCE CYSTIC DILATATION RENAL TUBULE","ABNORMAL RENAL TUBULE MORPHOLOGY"
"435","INCREASE RENAL PATHOLOGY DUE TO VTG DEPOSITION","WEAKNESS DUE TO UPPER MOTOR NEURON DYSFUNCTION"
"436","INCREASE ALLERGIC RESPIRATORY HYPERSENSITIVITY RESPONSE","IMMUNOLOGIC HYPERSENSITIVITY"
"437","INCREASED INCOMPLETE ECDYSIS","INCOMPLETE PENETRANCE"
"438","ALTERED AMPHIBIAN METAMORPHOSIS","APOPTOSISRELATED NETWORK DUE TO ALTERED NOTCH3 IN OVARIAN CANCER"
"439","REDUCED HEARING","PROGRESSIVE HEARING IMPAIRMENT"
"440","FEMINISATION OR INCOMPLETE DEVELOPMENT PRIMARY AND ACCESSORY MALE SEX ORGANS","ABNORMALITY OF THE ABDOMINAL ORGANS"
"441","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION","CARDIOVASCULAR CALCIFICATION"
"442","OCCURRENCE CYTOPLASMIC VACUOLIZATION RENAL TUBULE","ABNORMAL RENAL TUBULE MORPHOLOGY"
"443","REDUCED POSTERIOR SWIM BLADDER INFLATION","ABNORMALITY OF THE BLADDER"
"444","REDUCED ANTERIOR SWIM BLADDER INFLATION","ABNORMALITY OF THE BLADDER"
"445","DECREASED SODIUM REABSORPTION","ABNORMAL BLOOD SODIUM CONCENTRATION"
"446","CLONAL EXPANSION/CELL PROLIFERATION TO FORM ALTERED HEPATIC FOCI AHF","ABNORMAL FORM OF THE VERTEBRAL BODIES"
"447","INDUCTION LIVER ??DYSFUNCTIONAL??CHANGES BY CGA 330050","ABNORMAL LIVER MORPHOLOGY"
"448","DECREASED TESTOSTERONE BY THE FETAL LEYDIG CELLS DYSGENESIS OF FETAL LEYDIG CELLS","ABNORMALITY OF THE LEYDIG CELLS"
"449","DECREASED TESTOSTERONE BY FETAL LEYDIG CELLS DYSGENESIS OF FETAL LEYDIG CELLS","ABNORMALITY OF THE LEYDIG CELLS"
"450","DECREASED TESTOSTERONE BY THE FETAL LEYDIG CELLS DYSGENSIS OF FETAL LEYDIG CELLS","ABNORMALITY OF THE LEYDIG CELLS"
"451","DECREASED RENAL ABILITY TO DILUTE URINE","DELAYED ABILITY TO WALK"
"452","LOSS COCHLEAR FUNCTION","VISUAL LOSS"
"453","INDUCTION ATAXIA PARALYSIS OR HYPERACTIVITY","HYPERACTIVITY"
"454","INCREASED ATAXIA PARALYSIS OR HYPERACTIVITY","HYPERACTIVITY"
"455","N/A ATAXIA PARALYSIS OR HYPERACTIVITY","HYPERACTIVITY"
"456","INCREASED WATER RETENTION IN FOOT INCREASED WATER RETENTION IN FOOT","SHORT FOOT"
"457","INCREASE PERICARDIAL EDEMA","PERICARDIAL EFFUSION"
"458","INFLAMMATION LIVER","ABNORMAL LIVER MORPHOLOGY"
"459","INCREASED GLOMERULAR RUPTURE AND RENAL HEMORRHAGING","GLOMERULAR SCLEROSIS"
"460","INCREASED RESPIRATORY DISTRESS/ARREST","ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY"
"461","INCREASE SITE OF CONTACT NASAL TUMORS","POOR EYE CONTACT"
"462","INCREASED DEGENERATION OF DOPAMINERGIC NEURONS OF THE NIGROSTRIATAL PATHWAY","NICOTINE ACTIVITY ON DOPAMINERGIC NEURONS"
"463","N/A LIVER FIBROSIS","ABNORMAL LIVER MORPHOLOGY"
"464","ALTERED NEUROPHYSIOLOGY","APOPTOSISRELATED NETWORK DUE TO ALTERED NOTCH3 IN OVARIAN CANCER"
"465","INCREASE VASCULAR RESISTANCE","INCREASED PULMONARY VASCULAR RESISTANCE"
"466","INCREASED SERUM CREATININE","INCREASED SERUM SEROTONIN"
"467","NA LUNG FIBROSIS","LUNG FIBROSIS"
"468","INCREASE RBC CONGESTION IN LIVER","ABNORMAL LIVER MORPHOLOGY"
"469","INCREASE URINARY BLADDER CALCULI","ABNORMALITY OF THE BLADDER"
"470","OCCURRENCE CYTOPLASMIC VACUOLIZATION PODOCYTE","CYTOPLASMIC RIBOSOMAL PROTEINS"
"471","OCCURRENCE KIDNEY TOXICITY","FLUOROACETIC ACID TOXICITY"
"472","REDUCTION PLASMA 17BETA-ESTRADIOL CONCENTRATIONS","DECREASED PLASMA CARNITINE"
"473","DECREASED THYROXIN T4 IN NEURONAL TISSUE","DECREASED ADIPOSE TISSUE"
"474","ALTERED HIPPOCAMPAL ANATOMY","APOPTOSISRELATED NETWORK DUE TO ALTERED NOTCH3 IN OVARIAN CANCER"
"475","INCREASED ATRIOVENTRICULAR BLOCK AND BRADYCARDIA","BRADYCARDIA"
"476","MALFORMATION MALE REPRODUCTIVE TRACT","MALE REPRODUCTIVE SYSTEM NEOPLASM"
"477","REDUCTION PLASMA VITELLOGENIN CONCENTRATIONS","DECREASED PLASMA CARNITINE"
"478","REDUCTION GONADOTROPINS CIRCULATING CONCENTRATIONS","ABNORMAL CIRCULATING RENIN"
"479","INCREASE PLASMA VITELLOGENIN CONCENTRATIONS","DECREASED PLASMA CARNITINE"
"480","INCREASE LIVER AND SPLENIC HEMOSIDEROSIS","ABNORMAL LIVER MORPHOLOGY"
"481","N/A METHEMOGLOBINEMIA DECREASED HEMOGLOBIN HEMATOCRIT RED BLOOD CELL NUMBER","PURE RED CELL APLASIA"
"482","N/A LIVER STEATOSIS","RENAL STEATOSIS"
"483","ACCUMULATION FATTY ACID","ABNORMAL CIRCULATING FATTY ACID CONCENTRATION"
"484","INCREASED LIVER STEATOSIS","RENAL STEATOSIS"
"485","SENSITISATION SKIN","NEOPLASM OF THE SKIN"
"486","FORMATION HEPATOCELLULAR AND BILE DUCT TUMORS","HEPATOCELLULAR CARCINOMA"
"487","INCREASED RENAL VITELLOGENIN DEPOSITION","ABNORMAL RENAL MORPHOLOGY"
"488","REDUCED PROSTAGLANDINS OVARY","ABNORMALITY OF THE OVARY"
"489","DECREASED CHOLESTEROL DECREASED SPERM QUANTITY AND/OR QUALITY IN THE ADULT TESTIS","ABNORMAL HAIR QUANTITY"
"490","ACCUMULATION HIGHLY CARBOXYLATED PORPHYRINS","HIGHLY ARCHED EYEBROW"
"491","OCCURRENCE CARDIAC ARRHYTHMIA OCCURRENCE CARDIAC ARRHYTHMIA","VENTRICULAR ARRHYTHMIA"
"492","DECREASED POSITIVE ESTROGENIC FEEDBACK ON HYPOTHALAMUS REDUCED ESTRADIOL IN CIRCULATION DECREASES ESTROGEN CONCENTRATION AT HYPOTHALAMUS","ABNORMAL HYPOTHALAMUS PHYSIOLOGY"
"493","DECREASED BILE FLOW","DRUG INDUCTION OF BILE ACID PATHWAY"
"494","INCREASED CHOLESTASIS","CHOLESTASIS"
"495","INCREASED PANCREATIC ACINAR TUMORS","PANCREATIC HYPOPLASIA"
"496","INCREASED CIRCULATING ESTROGEN LEVELS","ABNORMAL CIRCULATING ESTROGEN LEVEL"
"497","OCCURRENCE CARDIAC ARRHYTHMIA","VENTRICULAR ARRHYTHMIA"
"498","INDUCTION MALE REPRODUCTIVE TRACT","MALE REPRODUCTIVE SYSTEM NEOPLASM"
"499","INCREASE ADENOMAS/CARCINOMAS RENAL TUBULAR","RENAL TUBULAR DYSFUNCTION"
"500","INCREASE ADENOMAS/CARCINOMAS HEPATOCELLULAR","HEPATOCELLULAR CARCINOMA"
"501","HYPERPLASIA HYPERPLASIA","ADRENAL HYPERPLASIA"
"502","INCREASE HYPERPLASIA OF GOBLET CELLS","ADRENAL HYPERPLASIA"
"503","INCREASED HYPERPLASIA FOLLICULAR CELLS","ADRENAL HYPERPLASIA"
"504","HYPERPLASIA OVARIAN EPITHELIUM","ABNORMAL CORNEAL EPITHELIUM MORPHOLOGY"
"505","INCREASED HYPERPLASIA MAMMARY GLAND","ADRENAL HYPERPLASIA"
"506","INCREASED DUCTAL HYPERPLASIA","ADRENAL HYPERPLASIA"
"507","OCCURRENCE RENAL ISCHEMIA","TISSUE ISCHEMIA"
"508","INCREASE METAPLASIA OF GOBLET CELLS","ABNORMALITY OF THE LEYDIG CELLS"
"509","REDUCED FITNESS OR EVEN MORTALITY ACIDOSIS HYPOVOLEMIC SHOCK AND ORGAN DYSFUNCTION","MORTALITY AGING"
"510","DECREASED GLOMERULAR FILTRATION","GLOMERULAR SCLEROSIS"
"511","INCREASED HEPATIC THYROID HORMONE UPTAKE/TRANSPORT","ABNORMAL THYROID HORMONE LEVEL"
"512","UNDER CARBOXYLATED CLOTTING FACTORS WILL NOT ASSEMBLE ON CELL SURFACES TO FORM CLOT FAILURE OF SECONDARY HEMOSTASIS","FAILURE TO THRIVE"
"513","HEMOSTASIS DEPLETION FROM BLOOD OF FULLY FUNCTIONAL CARBOXYLATED CLOTTING FACTORS","BLOOD CLOTTING CASCADE"
"514","REDUCTION VITELLOGENIN SYNTHESIS IN LIVER","ABNORMAL LIVER MORPHOLOGY"
"515","INCREASE VITELLOGENIN SYNTHESIS IN LIVER","ABNORMAL LIVER MORPHOLOGY"
"516","INCREASED APOB100","INCREASED HEMOGLOBIN"
"517","INCREASED VALVE MOVEMENT INCREASED VALVE MOVEMENT","PRENATAL MOVEMENT ABNORMALITY"
"518","AIRWAY HYPER-RESPONSIVENESSCOUGH DYSPNEA TRIGEMINAL AND/OR VAGAL NERVE EXCITATION","DYSPNEA"
"519","NA IRRITATION OF NASAL MUCOSA INDUCING SNEEZE REFLEX","ABNORMAL NASAL MUCOSA MORPHOLOGY"
"520","REDUCTION EXCITATORY POSTSYNAPTIC POTENTIAL","DISRUPTION OF POSTSYNAPTIC SIGNALLING BY CNV"
"521","GENERATION AMPLIFIED EXCITATORY POSTSYNAPTIC POTENTIAL EPSP","DISRUPTION OF POSTSYNAPTIC SIGNALLING BY CNV"
"522","CHRONIC MUCUS HYPERSECRETION CHRONIC MUCUS HYPERSECRETION","16P112 DISTAL DELETION SYNDROME"
"523","INCREASED PROLACTIN SECRETION","INCREASED CIRCULATING PROLACTIN CONCENTRATION"
"524","INDUCTION MICROVESICULAR FAT","FAT MALABSORPTION"
"525","INCREASED ADENOMAS PITUITARY","ABNORMALITY OF THE PITUITARY GLAND"
"526","HYPERPLASIA MAMMARY GLAND","ADRENAL HYPERPLASIA"
"527","INDUCTION SOMATIC MUSCLE PARALYSIS","PARALYSIS"
"528","INDUCTION PHARYNGEAL MUSCLE PARALYSIS","PARALYSIS"
"529","N/A NEUROINFLAMMATION","NEUROINFLAMMATION"
"530","NOT INCREASED CIRCULATING KETONE BODIES","SYNTHESIS AND DEGRADATION OF KETONE BODIES"
"531","N/A NEURODEGENERATION","NEURODEGENERATION"
"532","LEUKOCYTE INFILTRATION TISSUE IRRITATION/INFLAMMATION","ABNORMAL LEUKOCYTE COUNT"
"533","FORMATION LIVER FIBROSIS","ABNORMAL LIVER MORPHOLOGY"
"534","OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS","RENAL TUBULAR DYSFUNCTION"
"535","OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS","RENAL TUBULAR DYSFUNCTION"
"536","N/A HYPOXIA","16P112 DISTAL DELETION SYNDROME"
"537","INCREASE THYROID-STIMULATING HORMONE TSH","HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY"
"538","DECREASED RENAL PLASMA FLOW","DECREASED PLASMA CARNITINE"
"539","DECREASED THYROXIN T4 IN SERUM","DECREASED LEVEL OF GABA IN SERUM"
"540","REDUCTION TESTOSTERONE LEVEL","ABNORMAL INSULIN LEVEL"
"541","REDUCTION PROSTAGLANDIN E2 CONCENTRATION","PROSTAGLANDIN SYNTHESIS AND REGULATION"
"542","REDUCTION EGGSHELL THICKNESS","ABNORMALITY OF CORNEAL THICKNESS"
"543","N/A GAP","SANDAL GAP"
"544","N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS","OVERVIEW OF NANOPARTICLE EFFECTS"
"545","INCREASED CYCLIC ADENOSINE MONOPHOSPHATE","ELEVATED RED CELL ADENOSINE DEAMINASE LEVEL"
"546","REDUCED PROSTAGLANDIN E2 CONCENTRATION HYPOTHALAMUS","ABNORMAL HYPOTHALAMUS PHYSIOLOGY"
"547","REDUCED GONADOTROPIN RELEASING HORMONE HYPOTHALAMUS","HYPOTHALAMIC GONADOTROPIN RELEASING HORMONE DEFICIENCY"
"548","REDUCED LUTEINIZING HORMONE LH PLASMA","DECREASED CIRCULATING LUTEINIZING HORMONE LEVEL"
"549","REDUCED MATURATION INDUCING STEROID PLASMA","ABNORMALITY OF SKELETAL MATURATION"
"550","INCREASED ACCUMULATION OF ALPHA2U MICROGLOBULIN PROXIMAL TUBULAR EPITHELIUM","ABNORMAL CORNEAL EPITHELIUM MORPHOLOGY"
"551","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR","16P112 DISTAL DELETION SYNDROME"
"552","DECREASE SERUM THYROID HORMONE T4/T3","ABNORMAL THYROID HORMONE LEVEL"
"553","INCREASE ADENOMAS/CARCINOMAS FOLLICULAR CELL","FOLLICULAR HYPERKERATOSIS"
"554","INCREASED LUTEINIZING HORMONE LH","DECREASED CIRCULATING LUTEINIZING HORMONE LEVEL"
"555","DECREASED PROLACTIN","ABNORMAL PROLACTIN LEVEL"
"556","INCREASE ENDOMETRIAL ADENOCARCINOMAS","ENDOMETRIAL CANCER"
"557","INCREASED PLASMA TYROSINE","DECREASED PLASMA CARNITINE"
"558","INCREASED LEUTINIZING HORMONE LH","ABNORMAL CIRCULATING HORMONE LEVEL"
"559","INCREASE ADENOMAS/CARCINOMAS UROTHELIAL","16P112 DISTAL DELETION SYNDROME"
"560","DECREASED THYROXINE T4 IN SERUM","DECREASED LEVEL OF GABA IN SERUM"
"561","INCREASE RESPIRATORY OR SQUAMOUS METAPLASIA","SQUAMOUS CELL CARCINOMA"
"562","INCREASED BLOOD URIC ACID CONCENTRATION INCREASED BLOOD URIC ACID CONCENTRATION","ABNORMAL BLOOD GLUCOSE CONCENTRATION"
"563","INCREASED BLOOD POTASSIUM CONCENTRATION INCREASED BLOOD POTASSIUM CONCENTRATION","ABNORMAL BLOOD POTASSIUM CONCENTRATION"
"564","OCCURRENCE TOPHI URATE DEPOSITION OCCURRENCE TOPHI URATE DEPOSITION","16P112 DISTAL DELETION SYNDROME"
"565","INCREASE CANCER","BLADDER CANCER"
"566","INCREASED FREE SERUM THYROXINE T4","INCREASED SERUM SEROTONIN"
"567","REDUCED ESTRADIOL IN CIRCULATION REDUCED STEROIDOGENIC PRODUCTION OF ESTRADIOL IN GRANULOSA CELLS LEADING TO DECREASED ESTRADIOL IN CIRCULATION","ABNORMALITY OF PULMONARY CIRCULATION"
"568","DECREASED SERUM T4/T3","DECREASED LEVEL OF GABA IN SERUM"
"569","INCREASED THYROID-STIMULATING HORMONE TSH","HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY"
"570","INCREASED APOPTOSIS ADENOMAS/CARCINOMAS FOLLICULAR CELL","APOPTOSIS"
"571","INCREASED FIRBROSARCOMA","INCREASED HEMOGLOBIN"
"572","INCREASED LIPOSARCOMA","INCREASED HEMOGLOBIN"
"573","INCREASED HEMAGIOSARCOMA","INCREASED HEMOGLOBIN"
"574","PROMOTION MESOVARIAN LEIOMYOMAS","16P112 DISTAL DELETION SYNDROME"
"575","DECREASED OVARIAN E2","ABNORMAL OVARIAN MORPHOLOGY"
"576","PROMOTION OVARIAN ADENOMAS","ABNORMAL OVARIAN MORPHOLOGY"
"577","DECREASE E2 BLOOD CONCENTRATIONS AT HYPOTHALAMUS","ABNORMAL HYPOTHALAMUS PHYSIOLOGY"
"578","PROLONGED ELEVATION OF SERUM CCK","PROLONGED NEONATAL JAUNDICE"
"579","SQUAMOUS METAPLASIA ABERRANT BASAL CELLS","SQUAMOUS CELL CARCINOMA"
"580","INCREASED ADENOSQUAMOUS CARCINOMAS OF ENDOMETRIUM","ABNORMALITY OF THE ENDOMETRIUM"
"581","INCREASED PROLACTIN EXPOSURE","INCREASED CIRCULATING PROLACTIN CONCENTRATION"
"582","INCREASED ADENOMAS/CARCINOMAS MAMMARY","INCREASED HEMOGLOBIN"
"583","INCREASED MESOTHELIOMAS","INCREASED HEMOGLOBIN"
"584","DECREASED THYROXINE T4 IN TISSUES","ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES"
"585","DECREASED TRIIODOTHYRONINE T3 IN TISSUES","ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES"
"586","DECREASED PROSTAGLANDIN F2ALPHA CONCENTRATION PLASMA","DECREASED PLASMA CARNITINE"
"587","INCREASED BLOOD POTASSIUM CONCENTRATION","ABNORMAL BLOOD POTASSIUM CONCENTRATION"
"588","INCREASED BLOOD URIC ACID CONCENTRATION","INCREASED BLOOD PRESSURE"
"589","OCCURRENCE TOPHI URATE DEPOSITION","16P112 DISTAL DELETION SYNDROME"
"590","INCREASED TRIIODOTHYRONINE T3 IN TISSUES","ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES"
"591","NA COLLAGEN DEPOSITION","TYPE I COLLAGEN SYNTHESIS IN THE CONTEXT OF OSTEOGENESIS IMPERFECTA"
"592","INCREASED APPETITE AND HUNGER","POOR APPETITE"
"593","INCREASED DISEASE SUSCEPTIBILITY","INCREASED SUSCEPTIBILITY TO FRACTURES"
"594","IMPAIRED FERTILITY","DECREASED FERTILITY"
"595","PROMOTION HEPATOCELLUAR CARCINOMA","CARCINOMA"
"596","SUPPRESSION SUPPRESSION OF TRANSPLANT REJECTION","ALLOGRAFT REJECTION"
"597","INCREASE MORTALITY","MORTALITY AGING"
"598","INCREASE MORTALITY INCREASE MORTALITY","MORTALITY AGING"
"599","INCREASED MORTALITY","MORTALITY AGING"
"600","INCREASE HERITABLE MUTATIONS IN OFFSPRING","NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA"
"601","INCREASE ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS","OXIDATIVE STRESS"
"602","INCREASED ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS","OXIDATIVE STRESS"
"603","REDUCED YOUNG OF YEAR SURVIVAL","YOUNG ADULT ONSET"
"604","OSTEOPOROSIS AND VASCULAR CALCIFICATION BONE DETERIORATION","VASCULAR CALCIFICATION"
"605","ALTERED LARVAL DEVELOPMENT","HEART DEVELOPMENT"
"606","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS","ABNORMALITY OF THE ABDOMINAL ORGANS"
"607","IMPAIRED DEVELOPMENT","HEART DEVELOPMENT"
"608","PROLONGED ESTRUS","PROLONGED NEONATAL JAUNDICE"
"609","ABNORMAL FORAGING ACTIVITY AND BEHAVIOR","ABNORMAL SOCIAL BEHAVIOR"
"610","REDUCED PHEROMONE RELEASE","REDUCED CIRCULATING PROLACTIN CONCENTRATION"
"611","INCREASED NEPHROPATHY","NEPHROPATHY"
"612","INDUCTION SUSTAINED HEPATOTOXICITY","DRUG INDUCTION OF BILE ACID PATHWAY"
"613","N/A HYPERTENSION","HYPERTENSION ASSOCIATED WITH PHEOCHROMOCYTOMA"
"614","DECREASED BODY WEIGHT","DECREASED BODY WEIGHT"
"615","DECREASED DECREASED FECUNDITY","DECREASED FERTILITY"
"616","DELAYED OVULATION","DELAYED MYELINATION"
"617","INTERRUPTION OVULATION","16P112 DISTAL DELETION SYNDROME"
"618","INCREASED VIRAL SUSCEPTIBILITY","INCREASED SUSCEPTIBILITY TO FRACTURES"
"619","INCREASED KIDNEY FAILURE","RESPIRATORY FAILURE"
"620","INCREASED OXIDATIVE DAMAGE","OXIDATIVE DAMAGE"
"621","INCREASE ANEUPLOID OFFSPRING","16P112 DISTAL DELETION SYNDROME"
"622","N/A UROPORPHYRIA","16P112 DISTAL DELETION SYNDROME"
"623","INCREASE EMBRYOLETHALITY","16P112 DISTAL DELETION SYNDROME"
"624","INCREASED LATENCY PERIOD","INCREASED HEMOGLOBIN"
"625","DECREASED SHELTERING","DECREASED FERTILITY"
"626","DECREASED ANXIETY","SEROTONIN AND ANXIETY"
"627","OCCURRENCE EPILEPTIC SEIZURE","PSYCHOGENIC NON EPILEPTIC SEIZURE"
"628","INCREASED BURROWING","INCREASED HEMOGLOBIN"
"629","REDUCED FEEDING","TUBE FEEDING"
"630","INHIBITION FEEDING","TUBE FEEDING"
"631","REDUCED ABILITY TO ATTRACT SPAWNING MATES","DELAYED ABILITY TO WALK"
"632","REDUCED SWIMMING SPEED","REDUCED CIRCULATING PROLACTIN CONCENTRATION"
"633","REDUCED SWIMMING PERFORMANCE","REDUCED CIRCULATING PROLACTIN CONCENTRATION"
"634","DECREASED POPULATION TRAJECTORY","DECREASED FERTILITY"
"635","DECREASE POPULATION TRAJECTORY","SLOW DECREASE IN VISUAL ACUITY"
"636","DECREASE LUNG FUNCTION DECREASE LUNG FUNCTION","ABNORMAL LUNG MORPHOLOGY"
"637","DECREASED SPERM QUANTITY OR QUALITY IN THE ADULT DECREASED FERTILITY","DECREASED FERTILITY"
"638","REDUCTION CUMULATIVE FECUNDITY AND SPAWNING","APOE AND MIR146 IN INFLAMMATION AND ATHEROSCLEROSIS"
"639","DECREASED FERTILITY REDUCED NUMBER OF OOCYTES OVULATED","DECREASED FERTILITY"
"640","INCREASED PARKINSONIAN MOTOR DEFICITS","MOTOR SEIZURE"
"641","DECREASED LYMPHOCYTES","DECREASED FERTILITY"
"642","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY","ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY"
"643","CHOLESTASIS PATHOLOGY","CHOLESTASIS"
"644","N/A CYANOSIS OCCURS","CYANOSIS"
"645","FORMATION LIVER TUMOR","ABNORMAL LIVER MORPHOLOGY"
"646","TUMORIGENESIS HEPATOCELLULAR CARCINOMA","HEPATOCELLULAR CARCINOMA"
"647","DECREASED SPERM QUANTITY / QUALITY IN THE ADULT DECREASED FERTILITY","DECREASED FERTILITY"
"648","DECREASED FERTILITY IN THE ADULT DECREASED SPERM QUANTITY AND/OR QUALITY IN THE ADULT TESTIS","ADULT ONSET"
"649","INCREASED AMPUTATIONS","INCREASED HEMOGLOBIN"
"650","N/A SEDATION","16P112 DISTAL DELETION SYNDROME"
"651","REDUCED PROSTAGLANDIN F2ALPHA CONCENTRATION PLASMA","PROSTAGLANDIN SYNTHESIS AND REGULATION"
"652","REDUCED SPAWNING BEHAVIOR","INAPPROPRIATE BEHAVIOR"
"653","DECREASED FERTILITY","DECREASED FERTILITY"
"654","DECREASED TESTOSTERONE","DECREASED FERTILITY"
"655","MALFORMED MALE REPRODUCTIVE TRACT","MALE REPRODUCTIVE SYSTEM NEOPLASM"
"656","INCREASED DEFORMED WING VIRUS LEVELS","ABNORMALITY OF THE WING OF THE ILIUM"
"657","INDUCED SPAWNING INDUCED SPAWNING","NANOMATERIAL INDUCED APOPTOSIS"
"658","N/A BREAST CANCER","BREAST CANCER PATHWAY"
"659","NA INFANT LEUKAEMIA","SUDDEN INFANT DEATH SYNDROME SIDS SUSCEPTIBILITY PATHWAYS"
"660","INCREASE MUTATIONS","SOMATIC MUTATION"
"661","INCREASE MUTATIONS IN CRITICAL GENES","SOMATIC MUTATION"
"662","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME","PYRUVATE METABOLIC PROCESS"
"663","UP REGULATION ACETYL-COA CARBOXYLASE-1 ACC-1","CTOME FATTY ACYL COA BIOSYNTHESIS"
"664","ACTIVATION FAS","FAS LIGAND FASL PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS HSP REGULATION"
"665","INHIBITION THYROPEROXIDASE","HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY"
"666","ANTAGONISM HISTAMINE RECEPTOR H2","RESPONSE TO HISTAMINE"
"667","INHIBITION CA++ ATPASE","REGULATION OF ATPASE ACTIVITY"
"668","N/A PARENT COMPOUND IS CONVERTED TO THE REACTIVE METABOLITE AND FORMS FREE RADICALS LEADING TO OXIDATION OF HEME IRONII IN HEMOGLOBIN TO IRONIII",NA
"669","INHIBITION BILE SALT EXPORT PUMP ABCB11","BILE ACID AND BILE SALT TRANSPORT"
"670","INHIBITION NA+/I- SYMPORTER NIS","CELLULAR SODIUM ION HOMEOSTASIS"
"671","INDUCTION NUCLEAR RECEPTOR E75B GENE",NA
"672","SUPPRESSION FTZ-F1 GENE",NA
"673","INCREASE COX-2 EXPRESSION INCREASE COX-2 EXPRESSION","RELATIONSHIP BETWEEN INFLAMMATION COX2 AND EGFR"
"674","UP REGULATION CD36",NA
"675","ACTIVATION SCD-1",NA
"676","INCREASED SCD-1",NA
"677","UP REGULATION CYP1A1","ARYL HYDROCARBON RECEPTOR PATHWAY"
"678","UP REGULATION SCD-1",NA
"679","UP REGULATION FAS","FAS LIGAND FASL PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS HSP REGULATION"
"680","DOWN REGULATION CPT1A",NA
"681","DOWN REGULATION HMGCS2",NA
"682","INDUCTION CYP1A2/CYP1A5",NA
"683","INDUCTION DOUBLESEX1 GENE",NA
"684","NA DECOMPARTMENTALIZATION",NA
"685","INHIBITION ETHER-A-GO-GO ERG VOLTAGE-GATED POTASSIUM CHANNEL","REGULATION OF POTASSIUM ION TRANSPORT"
"686","INHIBITION SODIUM CHANNEL","REGULATION OF SODIUM ION TRANSPORT"
"687","MODULATION SODIUM CHANNEL","REGULATION OF SODIUM ION TRANSPORT"
"688","ACTIVATION PREGNANE-X RECEPTOR NR1L2","PREGNANE X RECEPTOR PATHWAY"
"689","INHIBITION NMDARS","CTOME ACTIVATION OF AMPK DOWNSTREAM OF NMDARS"
"690","ACTIVATION 5HT2C",NA
"691","ACTIVATION LXR","LIVER X RECEPTOR PATHWAY"
"692","ACTIVATION CHREBP",NA
"693","OVERACTIVATION NMDARS","CTOME ACTIVATION OF AMPK DOWNSTREAM OF NMDARS"
"694","ACTIVATION SREBF1","CTOME ACTIVATION OF GENE EXPRESSION BY SREBF SREBP"""
"695","SUPPRESSION HNF4ALPHA",NA
"696","INHIBITION FOXA2",NA
"697","ACTIVATION NR1H4","FARNESOID X RECEPTOR PATHWAY"
"698","ACTIVATION SHP",NA
"699","ACTIVATION LXR ALPHA","LIVER X RECEPTOR PATHWAY"
"700","ACTIVATION AKT2",NA
"701","DECREASED GNRH CFOS ACTIVITY","G GNRH SIGNALING PATHWAY"
"702","MODULATION UNKNOWN",NA
"703","INHIBITION ANTGONISM OF NE RECEPTOR","NOREPINEPHRINE METABOLIC PROCESS"
"704","INHIBITION P-AMINO HIPPURIC ACID CHANNEL",NA
"705","INHIBITION OF AROMATASE ENZYME CHEMICAL EXPOSURE DURING CRITICAL WINDOW OF ESTROUS CYCLE BETWEEN DIESTRUS 2 AND PROESTRUS INHIBITS AROMATASE CONVERSION OF TESTOSTERONE TO ESTRADIOL",NA
"706","INHIBITION PENDRIN",NA
"707","TRPA1 ACTIVATION TRPA1 RECEPTOR",NA
"708","TRPV1 ACTIVATION TRPV1",NA
"709","ACTIVATION JUVENILE HORMONE RECEPTOR",NA
"710","NA ACTIVATION OF TGF-?? SIGNALING","CANONICAL AND NONCANONICAL TGFB SIGNALING"
"711","ACTIVATION NADPH OXIDASE","CTOME RHO GTPASES ACTIVATE NADPH OXIDASES"
"712","DECREASED CHOLESTEROL DECREASED TRANSPORT OF CHOLESTEROL TO THE INNER MITOCHONDRIAL MEMBRANE","REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY"
"713","ACTIVATION SREBP-1C","STEROL REGULATORY ELEMENTBINDING PROTEINS SREBP SIGNALLIN"
"714","INHIBITION SREBP1C","STEROL REGULATORY ELEMENTBINDING PROTEINS SREBP SIGNALLIN"
"715","ACTIVATION ECDYSONE RECEPTOR",NA
"716","DECREASED TESTOSTERONE BY THE FETAL LEYDIG CELLS HYPERMETHYLATION IN THE FETAL TESTIS","ABNORMALITY OF THE LEYDIG CELLS"
"717","BINDING AT PICROTOXIN SITE IGABAR CHLORIDE CHANNEL","REGULATION OF CHLORIDE TRANSPORT"
"718","NA IN-UTERO DNA TOPOISOMERASE II ??POISONS-","ABNORMALITY OF DNA REPAIR"
"719","REDUCED PRESYNAPTIC RELEASE OF GLUTAMATE","SYNAPTIC TRANSMISSION GLUTAMATERGIC"
"720","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE","PEPTIDYL LYSINE MODIFICATION"
"721","INHIBITION INTERFERENCE OF NFAT COMPLEX FORMATION AT THE SITE OF NUCLEAR CYTOKINE PROMOTERS",NA
"722","NA DIRECT MITOCHONDRIAL INHIBITION","CTOME ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA"
"723","FAILURE IN GAMMA-GLUTAMYL CARBOXYLATION OF CLOTTING FACTORS II VII IX AND X UNDER CARBOXYLATION OF CLOTTING FACTORS EG DES-GAMMA-CARBOXY PROTHROMBIN",NA
"724","DECREASED TESTOSTERONE BY THE FETAL LEYDIG CELLS ALTERATIONS IN THE FETAL TESTIS PROTEOME","ABNORMALITY OF THE LEYDIG CELLS"
"725","DISPLACEMENT SERUM THYROXINE T4 FROM TRANSTHYRETIN","CTOME THYROXINE BIOSYNTHESIS"
"726","UNKNOWN MIE",NA
"727","NA MITOCHONDRIAL IMPAIRMENT","CTOME ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA"
